<DOC>
	<DOCNO>NCT01137955</DOCNO>
	<brief_summary>Celiac disease condition small intestine damage gluten , storage protein wheat similar protein barley rye . The disease cause different symptom diarrhea , bloating , abdominal pain weight loss . The majority patient respond gluten-free diet . However patient ( 5-30 % ) persistent symptom consider poor responder diet . Bacterial overgrowth small intestine account refractory patient . This study seek determine antibiotic therapy rifaximin relief symptoms patient poorly responsive gluten-free diet whether impact breath test result .</brief_summary>
	<brief_title>Rifaximin Treatment Persistent Symptoms Patients With Celiac Disease</brief_title>
	<detailed_description>A symptom questionnaire administer study initiation , 2 week 12 week . Patients undergo breath test involve drink sugar ( lactulose ) solution breathe machine . This technique identify presence bacteria small intestine . They randomly select receive either antibiotic ( rifaximin ) placebo three time day 10 day treat bacterial overgrowth .</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Adult patient age 18 old Biopsy proven celiac disease Persistent symptom diarrhea , gas , bloat and/or cramp despite gluten free diet least 1 month Women pregnant lactating include . All woman must document negative pregnancy test initiation study . Women become pregnant study ask discontinue study drug follow outcome pregnancy know . Women child bear potential must practice effective method birth control ( eg : prescription oral contraceptive , contraceptive injection , intrauterine device , double barrier method , contraceptive patch , male sterilization ) entry throughout treatment period . 1. antibiotic use indication within precede one month 2. use bismuth compound within precede month 3. concomitant use pancreatic supplement 4. concomitant use antispasmodic 5. concomitant use immunomodulators corticosteroid , budesonide , alkylating agent antimetabolite . 6. concomitant use probiotic 7. concomitant use prokinetic agent 8. concomitant use 5HT3 antagonist , 5HT4 agonist 9. concomitant use antimotility agent ( e.g loperamide ) 10. concomitant use antidiarrheal agent 11. diagnose microscopic colitis inflammatory bowel disease 12. cause malabsorption : pancreatic insufficiency , giardiasis enteropathy associate T cell lymphoma . 13. disease : renal hepatic insufficiency . 14. pregnant patient lactate female . In addition woman child bear age exclude use one method contraception like oral contraceptive , IUD double barrier method . 15. patient tuberculosis positive PPD test infection mycobaterial disease . 16. allergy and/or potential emergence drug resistance rifampicin rafamycin compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Gastrointestinal Symptom Rating Scale ( GSRS )</keyword>
	<keyword>Poorly responsive</keyword>
	<keyword>Refractory</keyword>
	<keyword>Small intestine bacterial overgrowth</keyword>
	<keyword>Breath test</keyword>
</DOC>